Lv4
500 积分 2021-12-31 加入
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future
16小时前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
17小时前
已完结
Altered immune landscape of cervical lymph nodes reveals Epstein-Barr virus signature in multiple sclerosis
21天前
已完结
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
6个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
6个月前
已完结
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
6个月前
已完结
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
6个月前
已完结
Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challenges
6个月前
已完结
Imaging chronic active lesions in multiple sclerosis: a consensus statement
6个月前
已完结
皖公网安备34019202002308
